stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
Free - Play StoreApp Store
InstallInstall
logo
Heron Therapeutics IncHRTX
$0.27263.42%-0.00965

Heron Therapeutics Inc (HRTX)

Heron Therapeutics Inc stock is traded at $0.2726, with a volume of 1,532,345. It is down -3.42% in the last 24 hours and down -24.50% over the past month. Heron Therapeutics Inc is a commercial-stage biotechnology company. The company is focused on improving the lives of patients by developing treatments and commercializing therapeutic solutions to address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.
Previous Close:
$0.2822
Open:
$0.28
24h Volume:
1,532,345
Relative Volume:
0.09
Market Cap:
$51.86M
Revenue:
$150.71M
Net Income/Loss:
-$30.94M
P/E Ratio:
-
EPS:
-$0.1767
Net Cash Flow:
-$20.86M
1W Performance:
-24.14%
1M Performance:
-24.50%
6M Performance:
-68.29%
1Y Performance:
-75.67%
1-Day Range:
$0.2696$0.287
1-Week Range:
$0.2664$0.3597
52-Week Range:
$0.261$1.58

Heron Therapeutics Inc Stock (HRTX) Company Profile

Name
Heron Therapeutics Inc
Phone
(858) 251-4400
Address
4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA, USA
Employee
128
X
-
Next Earnings Date
-
Latest SEC Filings
SEC
HRTX's Discussions on X
X

 

Market Cap

 

Revenue

 

Net Income

 

Cash Flow

 

EPS

 

Heron Therapeutics Inc Stock (HRTX) Financials Data

Similar to HRTX